Sign in

You're signed outSign in or to get full access.

Jessica Tasan

Vice President and Senior Research Analyst at Piper Sandler Companies

Jessica Tassan is a Vice President and Senior Research Analyst at Piper Sandler, specializing in healthcare IT and delivery. She covers specific companies including Alignment Healthcare (ALHC), Cigna (CI), CVS Health (CVS), Doximity (DOCS), Evolent Health (EVH), Health Catalyst (HCAT), Humana (HUM), Oscar Health (OSCR), Phreesia (PHR), Premier (PINC), Privia Health (PRVA), Teladoc Health (TDOC), and UnitedHealth Group (UNH), though specific performance metrics such as success rates or rankings on platforms like TipRanks are not publicly detailed. Tassan joined Piper Sandler in 2016 as an equity sales associate focused on healthcare investors in San Francisco, advancing to her current role by 2019, after prior experience at UBS in San Francisco and New York. She holds bachelor's degrees in economics and political science from the University of Connecticut.

Jessica Tasan's questions to UNITEDHEALTH GROUP (UNH) leadership

Question · Q4 2025

Jessica Tasan asked for key highlights from the independent reviews of UnitedHealth Group's business practices published in December. She also inquired if these reviews provide confidence in UHC and Optum Health's ability to manage risk adjustment reform.

Answer

Stephen Hemsley, Chairman and CEO, broadly stated that the independent reviews were positive, focusing on overall environments, controls, and governance, particularly in risk assessment. Company representative Chris added that the reports aim to advance trust and transparency, with additional reviews planned for 2026 focusing on metrics such as risk assessment accuracy, clinical policy accuracy, and pharmacy services.

Ask follow-up questions

Fintool

Fintool can predict UNITEDHEALTH GROUP logo UNH's earnings beat/miss a week before the call